S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Top 10 Searched Stocks on MarketBeat All-Access
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
3 Dividend Kings With Royally Good Upside
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Could trawler cams help save world's dwindling fish stocks?
Southwest Airlines brings back dividend as travel rebounds
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Top 10 Searched Stocks on MarketBeat All-Access
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
3 Dividend Kings With Royally Good Upside
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Could trawler cams help save world's dwindling fish stocks?
Southwest Airlines brings back dividend as travel rebounds
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Top 10 Searched Stocks on MarketBeat All-Access
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
3 Dividend Kings With Royally Good Upside
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Could trawler cams help save world's dwindling fish stocks?
Southwest Airlines brings back dividend as travel rebounds
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
Top 10 Searched Stocks on MarketBeat All-Access
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
3 Dividend Kings With Royally Good Upside
Minerals for Green Revolution a Massive Investor Opportunity (Ad)
Could trawler cams help save world's dwindling fish stocks?
Southwest Airlines brings back dividend as travel rebounds
OTCMKTS:ERFSF

Eurofins Scientific - ERFSF Stock Forecast, Price & News

$67.36
-3.05 (-4.33%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$67.36
▼
$68.20
50-Day Range
$56.10
▼
$73.82
52-Week Range
$54.75
▼
$127.01
Volume
75 shs
Average Volume
602 shs
Market Capitalization
$12.96 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$90.00

Eurofins Scientific MarketRank™ Forecast

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
33.6% Upside
$90.00 Price Target
Short Interest
Bearish
0.32% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.34mentions of Eurofins Scientific in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-2.45%
From $3.67 to $3.58 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.69 out of 5 stars

See Top Rated MarketRank™ Stocks Here
ERFSF stock logo

About Eurofins Scientific (OTCMKTS:ERFSF) Stock

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Receive ERFSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eurofins Scientific and its competitors with MarketBeat's FREE daily newsletter.

ERFSF Stock News Headlines

December 5, 2022 | finance.yahoo.com
Eurofins Launches BQ.1 and BQ.1.1 Droplet Digital PCR Assay (ddPCR) for SARS-CoV-2 Wastewater Testing
December 5, 2022 | finance.yahoo.com
Eurofins Agro Testing Supports CO2 Reduction with Soil Carbon Check Offering
December 2, 2022 | finance.yahoo.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2022
November 9, 2022 | finance.yahoo.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 October 2022
November 7, 2022 | finance.yahoo.com
EUROFINS - Weekly Report on Share Repurchase - 31th October - 4th November 2022
October 31, 2022 | finance.yahoo.com
Eurofins: Purchases of Own Shares from October, 24th to October, 28th 2022
October 27, 2022 | finance.yahoo.com
Eurofins Celebrates 35 Years of Testing for Life and 25 Years as Best Performing Share Listed in Europe
October 24, 2022 | finance.yahoo.com
EUROFINS - Weekly Report on share repurchase - 17th October - 21st October 2022
October 18, 2022 | finance.yahoo.com
Eurofins’ Core Business1 Organic Revenue Growth in Q3 2022 Accelerates to Its Mid-Term Objective
October 17, 2022 | finance.yahoo.com
Eurofins - Weekly Report on Share Repurchase - 10th October - 14th October 2022
October 10, 2022 | finance.yahoo.com
EUROFINS - Weekly Report on share repurchase - 03rd October - 07th October 2022
October 10, 2022 | finance.yahoo.com
French testing group Eurofins scouts for acquisitions in Asia
October 6, 2022 | finance.yahoo.com
Eurofins Viracor Opens Expansive Laboratory in Lenexa, KS
October 4, 2022 | finance.yahoo.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 September 2022
October 3, 2022 | finance.yahoo.com
Eurofins Viracor launches Epstein-Barr Virus (EBV) inSIGHT™ to Evaluate T Cell Mediated Immunity to Epstein-Barr Virus
October 3, 2022 | finance.yahoo.com
Eurofins Launches a Buy-Back Programme of Its Own Shares
October 3, 2022 | finance.yahoo.com
Eurofins Announces the Launch of the Largest European Biomonitoring Project for PFAS in Blood in Antwerp, Belgium
September 30, 2022 | finance.yahoo.com
Eurofins Scientific SE: Transplant Genomics announces launch of Trugraf® Liver, the first and only non-invasive gene expression diagnostic test to optimise immunosuppression in liver transplant recipients
September 27, 2022 | finance.yahoo.com
Eurofins Sacramento, in Collaboration with SCIEX USA, Achieves the Lowest Detection Limits for PFAS in Drinking Water
September 27, 2022 | finance.yahoo.com
Eurofins Sustainability Solutions Launched
September 26, 2022 | finance.yahoo.com
Eurofins divests its Digital Testing business
September 15, 2022 | seekingalpha.com
ERFSF Eurofins Scientific SE
September 8, 2022 | finance.yahoo.com
Eurofins Scientific SE (ERF.PA)
September 8, 2022 | finance.yahoo.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 August 2022
August 2, 2022 | finance.yahoo.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 July 2022
See More Headlines
Receive ERFSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eurofins Scientific and its competitors with MarketBeat's FREE daily newsletter.

ERFSF Company Calendar

Today
12/08/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ERFSF
Previous Symbol
NASDAQ:ERFSF
CUSIP
N/A
CIK
N/A
Web
www.eurofins.com
Phone
(522) 618-5320
Fax
N/A
Employees
58,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$90.00
High Stock Price Forecast
$110.00
Low Stock Price Forecast
$65.00
Forecasted Upside/Downside
+33.6%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$7.95 billion
Price / Sales
1.63
Cash Flow
$8.79 per share
Price / Cash Flow
7.66
Book Value
$28.78 per share
Price / Book
2.34

Miscellaneous

Outstanding Shares
192,470,000
Free Float
N/A
Market Cap
$12.96 billion
Optionable
Not Optionable
Beta
0.86

Key Executives

  • Dr. Gilles G. Martin Ph.D. (Age 59)
    Chairman & CEO
    Comp: $1.23M
  • Ms. Valerie Hanote (Age 56)
    Exec. Director
    Comp: $350.08k
  • Mr. Laurent Lebras
    Group Admin. & Fin. Director
  • Ms. Sandra Hoeylaerts
    Chief HR Officer
  • Mr. David W. Bryant
    Sr. VP of Strategic Bus. Devel. North America
  • Mr. Gabriel Julia
    Sr. VP of Clinical Diagnostics Europe
  • Dr. Timothy S. Oostdyk
    Exec. VP of BioPharma, Genomics & Agrosciences Services North America
  • Mr. Joachim Reichelt
    Sr. VP of Food & Feed Testing Europe
  • Ms. Yvoine Remy
    Sr. VP of Environment Testing Europe
  • Mr. Rajesh Saigal
    Exec. VP - Asia

Key Competitors

View All Competitors













ERFSF Stock - Frequently Asked Questions

Should I buy or sell Eurofins Scientific stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Eurofins Scientific in the last year. There are currently 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ERFSF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ERFSF, but not buy additional shares or sell existing shares.
View ERFSF analyst ratings or view top-rated stocks.

What is Eurofins Scientific's stock price forecast for 2023?

8 brokers have issued 1-year price objectives for Eurofins Scientific's shares. Their ERFSF share price forecasts range from $65.00 to $110.00. On average, they predict the company's stock price to reach $90.00 in the next year. This suggests a possible upside of 33.6% from the stock's current price.
View analysts price targets for ERFSF or view top-rated stocks among Wall Street analysts.

How have ERFSF shares performed in 2022?

Eurofins Scientific's stock was trading at $127.01 on January 1st, 2022. Since then, ERFSF stock has decreased by 47.0% and is now trading at $67.3580.
View the best growth stocks for 2022 here.

Are investors shorting Eurofins Scientific?

Eurofins Scientific saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 620,500 shares, an increase of 10.3% from the October 31st total of 562,800 shares. Based on an average daily volume of 900 shares, the days-to-cover ratio is currently 689.4 days.
View Eurofins Scientific's Short Interest.

What is Eurofins Scientific's stock symbol?

Eurofins Scientific trades on the OTCMKTS under the ticker symbol "ERFSF."

How do I buy shares of Eurofins Scientific?

Shares of ERFSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eurofins Scientific's stock price today?

One share of ERFSF stock can currently be purchased for approximately $67.36.

How much money does Eurofins Scientific make?

Eurofins Scientific (OTCMKTS:ERFSF) has a market capitalization of $12.96 billion and generates $7.95 billion in revenue each year.

How many employees does Eurofins Scientific have?

The company employs 58,000 workers across the globe.

How can I contact Eurofins Scientific?

Eurofins Scientific's mailing address is 23 Val Fleuri, Luxembourg N4, 1526. The official website for the company is www.eurofins.com. The company can be reached via phone at (522) 618-5320 or via email at ir@eurofins.com.

This page (OTCMKTS:ERFSF) was last updated on 12/8/2022 by MarketBeat.com Staff